Lifeloc Technologies, Inc (LCTC) stock
LCTCOTCLaboratory Analytical InstrumentsFiscal year ends December 31
$3.81−0.19 (-4.63%)
Close on Oct 19, 2026Market cap $10.50MP/E –Yield –
Lifeloc Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Lifeloc Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.03M, down 3.9% year over year. For fiscal 2025 it was $2.15M, down 4.0% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $2.24M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15M | -4.0% |
| FY2024 | Dec 31, 2024 | $2.24M | +22.2% |
| FY2023 | Dec 31, 2023 | $1.84M | +32.4% |
| FY2022 | Dec 31, 2022 | $1.39M | +14.2% |
| FY2021 | Dec 31, 2021 | $1.21M | +20.5% |
| FY2020 | Dec 31, 2020 | $1.01M | -3.0% |
| FY2019 | Dec 31, 2019 | $1.04M | -7.5% |
| FY2018 | Dec 31, 2018 | $1.12M | +4.2% |
| FY2017 | Dec 31, 2017 | $1.08M | +3.8% |
| FY2016 | Dec 31, 2016 | $1.04M | -15.3% |
| FY2015 | Dec 31, 2015 | $1.22M | +22.4% |
| FY2014 | Dec 31, 2014 | $1.00M | +7.6% |
| FY2013 | Dec 31, 2013 | $929.52K | +77.7% |
| FY2012 | Dec 31, 2012 | $523.06K | +18.7% |
| FY2011 | Dec 31, 2011 | $440.58K | +17.3% |
| FY2010 | Dec 31, 2010 | $375.68K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $560.28K | -10.1% |
| Q1 FY2026 | Mar 31, 2026 | $414.45K | -11.8% |
| Q4 FY2025 | Dec 31, 2025 | $601.15K | +19.3% |
| Q3 FY2025 | Sep 30, 2025 | $458.75K | -12.0% |
| Q2 FY2025 | Jun 30, 2025 | $623.26K | -5.9% |
| Q1 FY2025 | Mar 31, 2025 | $469.68K | -15.5% |
| Q4 FY2024 | Dec 31, 2024 | $503.89K | -4.3% |
| Q3 FY2024 | Sep 30, 2024 | $521.11K | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | $662.28K | +67.3% |
| Q1 FY2024 | Mar 31, 2024 | $555.60K | +40.0% |
| Q4 FY2023 | Dec 31, 2023 | $526.44K | +59.6% |
| Q3 FY2023 | Sep 30, 2023 | $516.17K | +64.9% |
| Q2 FY2023 | Jun 30, 2023 | $395.78K | +12.1% |
| Q1 FY2023 | Mar 31, 2023 | $396.77K | +1.7% |
| Q4 FY2022 | Dec 31, 2022 | $329.90K | -3.0% |
| Q3 FY2022 | Sep 30, 2022 | $313.09K | +4.5% |
| Q2 FY2022 | Jun 30, 2022 | $352.91K | +32.4% |
| Q1 FY2022 | Mar 31, 2022 | $390.02K | +27.0% |
| Q4 FY2021 | Dec 31, 2021 | $339.98K | +76.3% |
| Q3 FY2021 | Sep 30, 2021 | $299.65K | -10.6% |
| Q2 FY2021 | Jun 30, 2021 | $266.63K | +46.1% |
| Q1 FY2021 | Mar 31, 2021 | $307.21K | +3.5% |
| Q4 FY2020 | Dec 31, 2020 | $192.84K | -34.7% |
| Q3 FY2020 | Sep 30, 2020 | $335.08K | +32.1% |
| Q2 FY2020 | Jun 30, 2020 | $182.49K | -25.0% |
| Q1 FY2020 | Mar 31, 2020 | $296.90K | +20.8% |
| Q4 FY2019 | Dec 31, 2019 | $295.34K | +5.0% |
| Q3 FY2019 | Sep 30, 2019 | $253.72K | +1.9% |
| Q2 FY2019 | Jun 30, 2019 | $243.37K | -3.9% |
| Q1 FY2019 | Mar 31, 2019 | $245.80K | -27.3% |
| Q4 FY2018 | Dec 31, 2018 | $281.18K | -27.3% |
| Q3 FY2018 | Sep 30, 2018 | $249.09K | +2.9% |
| Q2 FY2018 | Jun 30, 2018 | $253.23K | +0.6% |
| Q1 FY2018 | Mar 31, 2018 | $338.33K | +72.3% |
| Q4 FY2017 | Dec 31, 2017 | $386.57K | +30.4% |
| Q3 FY2017 | Sep 30, 2017 | $242.01K | +16.3% |
| Q2 FY2017 | Jun 30, 2017 | $251.83K | – |
| Q1 FY2017 | Mar 31, 2017 | $196.37K | – |
| Q4 FY2016 | Dec 31, 2016 | $296.55K | – |
| Q3 FY2016 | Sep 30, 2016 | $208.09K | – |
See a number that looks wrong?